COUR Pharmaceuticals signs 50,000 square foot lease at Evanston Labs

Trammell Crow Company has signed a lease with COUR Pharmaceuticals at Evanston Labs in Evanston, Illinois. The company is relocating its headquarters, R&D lab, and pilot manufacturing plant to the recently delivered project. COUR Pharmaceuticals will occupy approximately 50,000 square feet across the eighth and ninth floors.

“Despite some headwinds in the current national market, we’ve continued to see great interest in our Evanston Labs development and are thrilled to welcome COUR Pharmaceuticals as our newest tenant,” said John Carlson, Principal with TCC Chicago. “With its prime location at the gateway of both Northwestern University and Evanston’s vibrant downtown, Evanston Labs is perfectly situated to attract the very best life sciences and other advanced sciences companies and talent that our region has to offer.”

COUR Pharmaceuticals is a clinical-stage biotechnology company developing therapies to treat patients with autoimmune diseases. COUR’s first-in-class therapies are based on its proprietary antigen-specific immune tolerance platform and are designed to reprogram the immune system to address the underlying root cause of immune-mediated diseases. Earlier this year, COUR Pharmaceuticals raised $105 million in a Series A round to advance multiple therapies to treat autoimmune diseases, including Type 1 Diabetes, Myasthenia Gravis, and Primary Biliary Cholangitis. The company’s move to Evanston Labs represents an expansion of the company’s current operations.

“Our move to Evanston Labs marks an exciting chapter in COUR’s journey. This state-of-the-art space will not only support our rapid growth but also enhance our ability to innovate in the development of groundbreaking therapies,” said Dannielle Appelhans, President and CEO of COUR Pharmaceuticals. “We believe this new environment will empower our team to expand our research capabilities and accelerate our mission of transforming treatment options for people living with autoimmune diseases.”

Located at the southwest corner of Orrington Avenue and Clark Street in Evanston, Evanston Labs is a 10-story, 178,800-sq.-ft. Class A advanced sciences lab building that was delivered earlier this year. The building includes lab and office space with spectacular views of Lake Michigan and the surrounding neighborhood. Each floorplate is designed to accommodate both single and multi-tenant users. There is also a floor dedicated to lab-ready graduation suites, ranging from 5,000 to 13,000 sq. ft. Building amenities include a penthouse amenity center for tenants, outfitted with a boardroom, a bar and lounge, an outdoor terrace, and a health and wellness center.